These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 34783554)

  • 1. Novel Sesquiterpene Glycoside from Loquat Leaf Alleviates Type 2 Diabetes Mellitus Combined with Nonalcoholic Fatty Liver Disease by Improving Insulin Resistance, Oxidative Stress, Inflammation, and Gut Microbiota Composition.
    Chen J; Ding X; Wu R; Tong B; Zhao L; Lv H; Meng X; Liu Y; Ren B; Li J; Jian T; Li W
    J Agric Food Chem; 2021 Dec; 69(47):14176-14191. PubMed ID: 34783554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sesquiterpene glycoside isolated from loquat leaf targets gut microbiota to prevent type 2 diabetes mellitus in db/db mice.
    Wu R; Zhou L; Chen Y; Ding X; Liu Y; Tong B; Lv H; Meng X; Li J; Jian T; Chen J
    Food Funct; 2022 Feb; 13(3):1519-1534. PubMed ID: 35072186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel sesquiterpene glycoside from Loquat leaf alleviates oleic acid-induced steatosis and oxidative stress in HepG2 cells.
    Jian T; Wu Y; Ding X; Lv H; Ma L; Zuo Y; Ren B; Zhao L; Tong B; Chen J; Li W
    Biomed Pharmacother; 2018 Jan; 97():1125-1130. PubMed ID: 29136950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Total sesquiterpene glycosides from Loquat (Eriobotrya japonica) leaf alleviate high-fat diet induced non-alcoholic fatty liver disease through cytochrome P450 2E1 inhibition.
    Jian T; Ao X; Wu Y; Lv H; Ma L; Zhao L; Tong B; Ren B; Chen J; Li W
    Biomed Pharmacother; 2017 Jul; 91():229-237. PubMed ID: 28458161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Jujuboside A through YY1/CYP2E1 signaling alleviated type 2 diabetes-associated fatty liver disease by ameliorating hepatic lipid accumulation, inflammation, and oxidative stress.
    Zhang W; Cheng Q; Yin L; Liu Y; Chen L; Jiang Z; Jiang X; Qian S; Li B; Wu M; Yin X; Wang T; Lu Q; Yang T
    Chem Biol Interact; 2024 Sep; 400():111157. PubMed ID: 39059604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.
    Porras D; Nistal E; Martínez-Flórez S; Pisonero-Vaquero S; Olcoz JL; Jover R; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
    Free Radic Biol Med; 2017 Jan; 102():188-202. PubMed ID: 27890642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liraglutide modulates gut microbiome and attenuates nonalcoholic fatty liver in db/db mice.
    Liu Q; Cai BY; Zhu LX; Xin X; Wang X; An ZM; Li S; Hu YY; Feng Q
    Life Sci; 2020 Nov; 261():118457. PubMed ID: 32961235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatoprotective Effect of Loquat Leaf Flavonoids in PM
    Jian T; Ding X; Wu Y; Ren B; Li W; Lv H; Chen J
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30275422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Correlation analysis of gut microbiota and biochemical indexes in patients with non-alcoholic fatty liver disease].
    Ren SM; Mei L; Huang H; Cao SF; Zhao RH; Zheng PY
    Zhonghua Gan Zang Bing Za Zhi; 2019 May; 27(5):369-375. PubMed ID: 31177662
    [No Abstract]   [Full Text] [Related]  

  • 10. [Zuogui Jiangtang Qinggan Prescription promotes recovery of intestinal mucosal barrier in mice with type 2 diabetes mellitus and nonalcoholic fatty liver disease by improving intestinal flora homeostasis].
    Zou JJ; Li H; Zhou M; Huang QQ; Wu YJ; Yu R
    Zhongguo Zhong Yao Za Zhi; 2023 Jan; 48(2):525-533. PubMed ID: 36725242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iron aggravates hepatic insulin resistance in the absence of inflammation in a novel db/db mouse model with iron overload.
    Altamura S; Müdder K; Schlotterer A; Fleming T; Heidenreich E; Qiu R; Hammes HP; Nawroth P; Muckenthaler MU
    Mol Metab; 2021 Sep; 51():101235. PubMed ID: 33872860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Tylophora yunnanensis Schltr on regulating the gut microbiota and its metabolites in non-alcoholic steatohepatitis rats by inhibiting the activation of NOD-like receptor protein 3.
    Lin YP; Fang QL; Xue YM; Fu SN; Hu CY; Huang F; Wang MM; Qiao X; Yin XQ; Zeng YC; Du CH; Zhao XJ; Li XP; Hua Y
    J Ethnopharmacol; 2023 Apr; 305():116145. PubMed ID: 36623753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting the gut microbiota with resveratrol: a demonstration of novel evidence for the management of hepatic steatosis.
    Wang P; Wang J; Li D; Ke W; Chen F; Hu X
    J Nutr Biochem; 2020 Jul; 81():108363. PubMed ID: 32388250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated omics analysis unraveled the microbiome-mediated effects of Yijin-Tang on hepatosteatosis and insulin resistance in obese mouse.
    Lee JE; Lee SM; Jung J
    Phytomedicine; 2020 Dec; 79():153354. PubMed ID: 32992082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quercetin improves nonalcoholic fatty liver by ameliorating inflammation, oxidative stress, and lipid metabolism in db/db mice.
    Yang H; Yang T; Heng C; Zhou Y; Jiang Z; Qian X; Du L; Mao S; Yin X; Lu Q
    Phytother Res; 2019 Dec; 33(12):3140-3152. PubMed ID: 31452288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Si Miao Formula attenuates non-alcoholic fatty liver disease by modulating hepatic lipid metabolism and gut microbiota.
    Han R; Qiu H; Zhong J; Zheng N; Li B; Hong Y; Ma J; Wu G; Chen L; Sheng L; Li H
    Phytomedicine; 2021 May; 85():153544. PubMed ID: 33773192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chicoric Acid Ameliorates Nonalcoholic Fatty Liver Disease via the AMPK/Nrf2/NF
    Ding X; Jian T; Li J; Lv H; Tong B; Li J; Meng X; Ren B; Chen J
    Oxid Med Cell Longev; 2020; 2020():9734560. PubMed ID: 33204402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fermented noni (
    Zhang X; Zhang B; Li L; Li X; Zhang J; Chen G
    Food Funct; 2022 Aug; 13(15):8254-8273. PubMed ID: 35833945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. α-Lactalbumin peptide Asp-Gln-Trp alleviates hepatic insulin resistance and modulates gut microbiota dysbiosis in high-fat diet-induced NAFLD mice.
    Chen H; Sun Y; Zhao H; Qi X; Cui H; Li Q; Ma Y
    Food Funct; 2022 Oct; 13(19):9878-9892. PubMed ID: 36052713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Yogurt improves insulin resistance and liver fat in obese women with nonalcoholic fatty liver disease and metabolic syndrome: a randomized controlled trial.
    Chen Y; Feng R; Yang X; Dai J; Huang M; Ji X; Li Y; Okekunle AP; Gao G; Onwuka JU; Pang X; Wang C; Li C; Li Y; Sun C
    Am J Clin Nutr; 2019 Jun; 109(6):1611-1619. PubMed ID: 31136662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.